Home › Funds › GordonMD Global Investments LP › BLCO
GordonMD Global Investments LP position in BLCO
BAUSCH PLUS LOMB CORP · Health Care
GordonMD Global Investments LP reported holding 475,472 shares of BLCO (BAUSCH PLUS LOMB CORP) in its Q3 2026 13F filing — a position valued at US$8.1M, representing 4.86% of its reported portfolio and ranking #9 among its reported holdings. GordonMD Global Investments LP has disclosed BLCO holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How GordonMD Global Investments LP's BLCO position evolved
GordonMD Global Investments LP first disclosed a stake in BLCO in Q4 2025 at 613,472 shares (US$10.5M). Across 4 filings, GordonMD Global Investments LP increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 475,472 shares valued at US$8.1M — a reduction of -98,000 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 613.47K | $10.48M | New |
| Q1 2026 | 573.47K | $9.12M | Reduce |
| Q2 2026 | 573.47K | $9.50M | Hold |
| Q3 2026 | 475.47K | $8.08M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About BLCO and 13F data
BLCO (BAUSCH PLUS LOMB CORP) is a Health Care company. 26 other funds we track also report a position in BLCO — the largest reported positions include OAKTREE CAPITAL MANAGEMENT LP (US$57.0M), Davidson Kempner Capital Management (US$52.3M), GOLDENTREE ASSET MANAGEMENT LP (US$44.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding BLCO
- OAKTREE CAPITAL MANAGEMENT LP 3.44M sh · $56.98M · Q2 2026
- Davidson Kempner Capital Management 3.16M sh · $52.31M · Q2 2026
- GOLDENTREE ASSET MANAGEMENT LP 2.66M sh · $43.96M · Q2 2026
- ICAHN CARL C 2.38M sh · $40.43M · Q3 2026
- GLENVIEW CAPITAL MANAGEMENT, LLC 1.92M sh · $31.76M · Q2 2026
- CASPIAN CAPITAL LP 1.42M sh · $24.18M · Q3 2026
- CLARK ESTATES INC/NY 881.00K sh · $14.98M · Q3 2026
- Clearline Capital LP 701.97K sh · $11.62M · Q2 2026
- Beach Point Capital Management LP 346.02K sh · $5.88M · Q3 2026
- SHENKMAN CAPITAL MANAGEMENT INC 277.75K sh · $5.00M · Q3 2026
- Ratan Capital Management LP 292.26K sh · $4.97M · Q3 2026
More on GordonMD Global Investments LP
FAQ
How long has GordonMD Global Investments LP held BLCO?
GordonMD Global Investments LP has disclosed BLCO holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is GordonMD Global Investments LP's current position in BLCO?
As of Q3 2026, GordonMD Global Investments LP holds 475.47K shares of BLCO (BAUSCH PLUS LOMB CORP), valued at $8.08M, representing 4.86% of its reported portfolio and ranking #9.
Has GordonMD Global Investments LP been buying or selling BLCO?
In the latest 13F filing (Q3 2026), GordonMD Global Investments LP reduced its position in BLCO.
Which other funds hold BLCO?
Other major institutional holders of BLCO include OAKTREE CAPITAL MANAGEMENT LP, Davidson Kempner Capital Management, GOLDENTREE ASSET MANAGEMENT LP, among 26 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.